Get started
Author

Javier Hernandez

Observed names: J. Hernandez, Javier Hernández
ORCID: 0000-0002-2666-5989
Observed ORCID: 0000-0002-2666-5989
OpenAlex ID: A5001615088
Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
2024 · Jordan P. Hartig, Kaitlyn Bejar, et al. · Cancer Research Communications · 10
Low-grade myofibroblastic sarcoma of the retroauricular region treated with complete circumferential peripheral and deep margin assessment surgery and local flap construction: A case report
2026 · Laura M. Umaña, María Pineda Muñoz, et al. · JAAD Case Reports
PDF
Figure S4 from Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
2026 · Jordan P. Hartig, Kaitlyn Bejar, et al.
Table S6 from Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
2026 · Jordan P. Hartig, Kaitlyn Bejar, et al.
Figure S13 from Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
2026 · Jordan P. Hartig, Kaitlyn Bejar, et al.
Table S1 from Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
2026 · Jordan P. Hartig, Kaitlyn Bejar, et al.
Figure S3 from Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
2026 · Jordan P. Hartig, Kaitlyn Bejar, et al.
Table S3 from Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
2026 · Jordan P. Hartig, Kaitlyn Bejar, et al.
Figure S12 from Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
2026 · Jordan P. Hartig, Kaitlyn Bejar, et al.
Figure S5 from Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
2026 · Jordan P. Hartig, Kaitlyn Bejar, et al.
Figure S18 from Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
2026 · Jordan P. Hartig, Kaitlyn Bejar, et al.
Figure S6 from Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
2026 · Jordan P. Hartig, Kaitlyn Bejar, et al.
Figure S17 from Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
2026 · Jordan P. Hartig, Kaitlyn Bejar, et al.
Figure S7 from Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
2026 · Jordan P. Hartig, Kaitlyn Bejar, et al.
Table S5 from Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
2026 · Jordan P. Hartig, Kaitlyn Bejar, et al.
Figure S1 from Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
2026 · Jordan P. Hartig, Kaitlyn Bejar, et al.
Figure S10 from Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
2026 · Jordan P. Hartig, Kaitlyn Bejar, et al.
Figure S2 from Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
2026 · Jordan P. Hartig, Kaitlyn Bejar, et al.
Figure S8 from Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
2026 · Jordan P. Hartig, Kaitlyn Bejar, et al.
Table S4 from Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
2026 · Jordan P. Hartig, Kaitlyn Bejar, et al.
Supplementary Data Figure Legends from Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
2026 · Jordan P. Hartig, Kaitlyn Bejar, et al.
Figure S11 from Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
2026 · Jordan P. Hartig, Kaitlyn Bejar, et al.
Figure S16 from Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
2026 · Jordan P. Hartig, Kaitlyn Bejar, et al.
Figure S14 from Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
2026 · Jordan P. Hartig, Kaitlyn Bejar, et al.
Figure S15 from Determining the N-Glycan and Collagen/Extracellular Matrix Protein Compositions in a Novel Outcome Cohort of Prostate Cancer Tissue Microarrays Using MALDI-MSI
2026 · Jordan P. Hartig, Kaitlyn Bejar, et al.
Works count: 88
Citation count: 10
H-index: 1
I10-index: 1
Year
Topic
Type